WBA Walgreens NASDAQ $11.98 16 Feb 2026: Volume spike signals active trading

WBA stock is trading at $11.98 on the NASDAQ in the United States during the intraday session on 16 Feb 2026. Volume has surged to 452,081,061.00 shares versus an average of 16,940,296.00, making Walgreens Boots Alliance one of the most active names today. Price sits near the 50-day average of $11.66 and above the 200-day average of $10.81, while the one-year range is $8.08–$13.25. We use real-time metrics and Meyka AI’s tools to link the trading spike to valuation and short-term technicals for active traders.

Intraday snapshot for WBA stock

The stock opened at $11.98 and is unchanged intraday at $11.98. Trade volume is 452,081,061.00, giving a relative volume of 26.69, which shows extreme intraday interest. Market capitalization is $10,369,421,068.00 and shares outstanding are 865,561,024.00. The immediate range performance places WBA between its year low $8.08 and year high $13.25.

Why the volume spike matters for WBA stock

A volume surge to 452,081,061.00 suggests either large block trades or algorithmic flows. High relative volume often precedes price discovery and wider spreads. For active traders, volume confirms conviction and can accelerate short-term trends in WBA stock.

Fundamentals and valuation for Walgreens Boots Alliance

Walgreens Boots Alliance shows negative EPS -7.29 and a negative P/E -1.64, reflecting recent losses and non-recurring items. Price-to-book is 1.44 and price-to-sales is 0.07, indicating low market valuation versus sales. Debt-to-equity is high at 4.04, and current ratio is 0.60, signaling liquidity pressure. These metrics shape near-term valuation debates around WBA stock.

Technical outlook and trading signals for WBA stock

Momentum indicators show a strong intraday trend with ADX 50.00 and RSI at 100.00 on provided data. Keltner channel middle is $11.93 with an upper band at $12.26, suggesting limited upside room today. Traders should watch the 50-day average $11.66 as immediate support and $13.25 as resistance on higher timeframes.

Meyka grade, analyst consensus and price targets

Meyka AI rates WBA with a score out of 100: 61.79 (Grade B) with suggestion HOLD. This grade factors S&P 500 and sector comparisons, financial growth, key metrics, and analyst consensus. MarketBeat shows a current price target of $9.00, and the consensus upgrade/downgrade mix reads one Hold and two Sell opinions. We note the DCF sub-score favored a higher intrinsic value amid mixed operational metrics. Meyka AI is an AI-powered market analysis platform used to synthesize these inputs.

Risks and opportunities for WBA stock traders

Risk drivers include high leverage, negative EPS, and low liquidity ratios. Opportunities include near-term momentum, retail pharmacy demand resilience, and a low price-to-sales multiple of 0.07. Active traders should weigh headline news, earnings on 2025-06-25, and evolving analyst views when sizing positions in WBA stock.

Final Thoughts

Key takeaways for WBA stock on 16 Feb 2026: price is $11.98 on NASDAQ with extreme intraday volume 452,081,061.00, marking it among today’s most active names. Valuation shows a mixed picture: low price-to-sales 0.07 but negative EPS -7.29 and a high debt-to-equity 4.04. MarketBeat’s price target of $9.00 implies a -24.87% downside versus the current price. Meyka AI’s forecast model projects $4.08, implying -65.96% downside versus $11.98. Forecasts are model-based projections and not guarantees. Traders should treat today’s volume spike as a short-term momentum signal, not as a substitute for fundamental risk assessment. Monitor upcoming earnings, analyst updates, and sector movement in Healthcare for direction on WBA stock

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.